A Study of C-CAR066 in Subjects With r/r Diffuse Large B Cell Lymphoma Who Received CD19 CAR-T Therapy
Clinical trial NCT04316624 · COMPLETED
Trial details
- NCT number
- NCT04316624
- Sponsor
- Institute of Hematology & Blood Diseases Hospital, China
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-09-29
- Primary completion
- 2023-02-08
- Enrollment
- 7
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.